Validity of the SNOT-22 as a Primary Outcome in Recurrent Acute Rhinosinusitis—Reply

Дата публикации: 08-10-2026 00:00:00

In Reply We thank Williams for their interest in our article and for their thoughtful critique of the trial.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Validity of the SNOT-22 as a Primary Outcome in Recurrent Acute Rhinosinusitis	0	7.05	08-10-2026
2	Kommentar zu Neue Reweprodukttests (Bewerbungsphase beginnt am 23.10.26) von leni94	0	28.18	16-10-2026
3	Facial Synkinesis Resting Phenotypes and Surgical Implications	0	11.34	15-10-2026
4	Diverse Research Teams and Underrepresented Groups in Clinical Studies	0	6.4	01-11-2023
5	A Comparative Study of Posterior Nasal Nerve Resection and Surface Coablation in the Management of Allergic Rhinitis [version 1; peer review: awaiting peer review]	0	6.83	10-08-2026
6	Ocular Symptoms After Refractive Surgery	0	5	09-07-2026
7	Etoricoxib Versus Diclofenac Sodium Intramuscular Injections in Acute Orthopaedic Pain Management: A Randomized, Open-Label Pilot Trial	0	19.09	19-08-2026
8	Clinical efficacy of transcervical epiglottopexy in infants with type Ⅲ laryngomalacia	0	15.88	19-08-2026
9	Endoscopic Versus Open Partial Plantar Fasciectomy for Solitary Plantar Fibromatosis: A Retrospective Cohort Study With Minimum 2-Year Follow-up	0	17.17	19-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.5. Источник: jamanetwork.com.